Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable quinine for severe malaria
jRCTs071180063Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jul 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of quinine in malaria, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: survival rate at 4 weeks. Started Jul 2017; status: completed.
02
Drugs
quinine
03
Conditions
malaria
Beyond the preview
Go deeper on jRCTs071180063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180063.